×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ARAY – accuray incorporated (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ARAY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/3
07:35 am
aray
Accuray CyberKnife® Platform Featured in New Studies Showcasing its Benefits in Central Nervous System Tumors Presented at Radiosurgery Society Scientific Meeting
Medium
Report
Accuray CyberKnife® Platform Featured in New Studies Showcasing its Benefits in Central Nervous System Tumors Presented at Radiosurgery Society Scientific Meeting
4/1
07:36 am
aray
ZAP-X Gyroscopic Radiosurgery Platform to Debut in Taiwan at Kaohsiung Show Chwan Memorial Hospital [Yahoo! Finance]
Low
Report
ZAP-X Gyroscopic Radiosurgery Platform to Debut in Taiwan at Kaohsiung Show Chwan Memorial Hospital [Yahoo! Finance]
3/30
09:14 am
aray
Accuray Incorporated (NASDAQ:ARAY): When Will It Breakeven? [Yahoo! Finance]
Low
Report
Accuray Incorporated (NASDAQ:ARAY): When Will It Breakeven? [Yahoo! Finance]
3/29
02:07 am
aray
Accuray Incorporated (NASDAQ: ARAY) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Accuray Incorporated (NASDAQ: ARAY) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
3/15
02:05 am
aray
Accuray Incorporated (NASDAQ: ARAY) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Medium
Report
Accuray Incorporated (NASDAQ: ARAY) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
3/12
07:57 am
aray
Accuray to Participate at 37th Annual Roth Conference [Yahoo! Finance]
Low
Report
Accuray to Participate at 37th Annual Roth Conference [Yahoo! Finance]
3/12
07:30 am
aray
Accuray to Participate at 37th Annual Roth Conference
Low
Report
Accuray to Participate at 37th Annual Roth Conference
3/11
10:27 am
aray
Robotic Radiotherapy Market is expected to generate a revenue of USD 2.95 Billion by 2032, Globally, at 11.6% CAGR: Verified Market Research® [Yahoo! Finance]
Medium
Report
Robotic Radiotherapy Market is expected to generate a revenue of USD 2.95 Billion by 2032, Globally, at 11.6% CAGR: Verified Market Research® [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/3
05:42 pm
aray
Form 4 ACCURAY INC For: Feb 28 Filed by: Peralta Leonel
Low
Report
Form 4 ACCURAY INC For: Feb 28 Filed by: Peralta Leonel
2/13
04:10 pm
aray
Form 3 ACCURAY INC For: Feb 03 Filed by: Peralta Leonel
Low
Report
Form 3 ACCURAY INC For: Feb 03 Filed by: Peralta Leonel
2/11
05:42 pm
aray
Form 144 ACCURAY INC Filed by: Hoge Michael
Low
Report
Form 144 ACCURAY INC Filed by: Hoge Michael
2/7
04:01 pm
aray
Form 8-K ACCURAY INC For: Feb 03
Low
Report
Form 8-K ACCURAY INC For: Feb 03
2/5
04:16 pm
aray
Form 10-Q ACCURAY INC For: Dec 31
Low
Report
Form 10-Q ACCURAY INC For: Dec 31
2/5
04:03 pm
aray
Form 8-K ACCURAY INC For: Feb 05
Medium
Report
Form 8-K ACCURAY INC For: Feb 05
1/21
10:34 am
aray
Form SCHEDULE 13G/A ACCURAY INC Filed by: Aevum Pension Fund
Low
Report
Form SCHEDULE 13G/A ACCURAY INC Filed by: Aevum Pension Fund
1/21
09:20 am
aray
Form 8-K ACCURAY INC For: Jan 21
Low
Report
Form 8-K ACCURAY INC For: Jan 21
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/28
Q3/2020 3/31/2020 EPS 0.030 ZacksConsensus -0.030 ActVsEst 0.060 - Beat
15.4%
1/28 Q2/2020 12/31/2019 EPS 0.120 ZacksConsensus -0.070 ActVsEst 0.190 - Beat 13.4%
12/25 Accuray Incorporated (NASDAQ: ARAY) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 8.2%
11/4 Form 4 ACCURAY INC For: Oct 31 Filed by: Chew Jesse 7.6%
11/1 Form 4 ACCURAY INC For: Oct 31 Filed by: Winter Suzanne C 7.4%
9/6 Form 4 ACCURAY INC For: Sep 04 Filed by: WHITTERS JOSEPH E 6.0%
2/11 Accuray Incorporated (NASDAQ: ARAY) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 5.6%
1/16 Accuray To Report Fiscal 2020 Second Quarter Financial Results on January 28, 2020 5.2%
1/21 Accuray Incorporated (NASDAQ: ARAY) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $9.50 price target on the stock. 5.2%
7/19 Accuray To Report Fiscal 2019 Fourth Quarter and Full Year Financial Results on August 15, 2019 4.7%
1/28 Q2/2020 12/31/2019 EPS 0.120 ZacksConsensus -0.070 ActVsEst 0.190 - Beat 13.4%
12/25 Accuray Incorporated (NASDAQ: ARAY) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 8.2%
11/4 Form 4 ACCURAY INC For: Oct 31 Filed by: Chew Jesse 7.6%
11/1 Form 4 ACCURAY INC For: Oct 31 Filed by: Winter Suzanne C 7.4%
9/6 Form 4 ACCURAY INC For: Sep 04 Filed by: WHITTERS JOSEPH E 6.0%
2/11 Accuray Incorporated (NASDAQ: ARAY) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 5.6%
1/16 Accuray To Report Fiscal 2020 Second Quarter Financial Results on January 28, 2020 5.2%
1/21 Accuray Incorporated (NASDAQ: ARAY) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $9.50 price target on the stock. 5.2%
7/19 Accuray To Report Fiscal 2019 Fourth Quarter and Full Year Financial Results on August 15, 2019 4.7%
TOP News Decliners
1/30
Accuray Incorporated (NASDAQ: ARAY) was upgraded by analysts at TheStreet from a "d" rating to a "c-" rating.
-11.0%
3/10 Accuray Incorporated (NASDAQ: ARAY) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -8.5%
8/15 Q4/2019 6/30/2019 EPS -0.020 ZacksConsensus 0.030 ActVsEst (0.050) - Miss -7.5%
8/2 Form 8-K ACCURAY INC For: Jul 30 -6.7%
4/28 Accuray Inc (ARAY) Q3 2020 Earnings Call Transcript [The Motley Fool] -5.9%
10/30 Accuray Drifting, And Critical Mass Seems Far Away [Seeking Alpha] -5.5%
9/17 Data Published in The Lancet Oncology Suggest CyberKnife® Prostate Patients Experienced Lower Levels of Acute Genitourinary Toxicity (Grade 2 or Higher) Than Patients Treated on a Conventional Linear Accelerator -5.2%
10/29 Q1/2020 9/30/2019 EPS -0.110 ZacksConsensus -0.100 ActVsEst (0.010) - Miss -4.8%
8/22 Form 8-K ACCURAY INC For: Aug 16 -4.7%
2/5 Studies Support Use of the Accuray TomoTherapy® System for Advanced Rectal Cancer to Improve Treatment Efficacy and Reduce Side Effects -4.3%
3/10 Accuray Incorporated (NASDAQ: ARAY) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -8.5%
8/15 Q4/2019 6/30/2019 EPS -0.020 ZacksConsensus 0.030 ActVsEst (0.050) - Miss -7.5%
8/2 Form 8-K ACCURAY INC For: Jul 30 -6.7%
4/28 Accuray Inc (ARAY) Q3 2020 Earnings Call Transcript [The Motley Fool] -5.9%
10/30 Accuray Drifting, And Critical Mass Seems Far Away [Seeking Alpha] -5.5%
9/17 Data Published in The Lancet Oncology Suggest CyberKnife® Prostate Patients Experienced Lower Levels of Acute Genitourinary Toxicity (Grade 2 or Higher) Than Patients Treated on a Conventional Linear Accelerator -5.2%
10/29 Q1/2020 9/30/2019 EPS -0.110 ZacksConsensus -0.100 ActVsEst (0.010) - Miss -4.8%
8/22 Form 8-K ACCURAY INC For: Aug 16 -4.7%
2/5 Studies Support Use of the Accuray TomoTherapy® System for Advanced Rectal Cancer to Improve Treatment Efficacy and Reduce Side Effects -4.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: